172 related articles for article (PubMed ID: 29725907)
1. Genetic Factors Associated with Postoperative Nausea and Vomiting: a Systematic Review.
López-Morales P; Flores-Funes D; Sánchez-Migallón EG; Lirón-Ruiz RJ; Aguayo-Albasini JL
J Gastrointest Surg; 2018 Sep; 22(9):1645-1651. PubMed ID: 29725907
[TBL] [Abstract][Full Text] [Related]
2. Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting.
Kim MS; Lee JR; Choi EM; Kim EH; Choi SH
Yonsei Med J; 2015 Sep; 56(5):1415-20. PubMed ID: 26256989
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of Postoperative Nausea and Vomiting.
Aroke EN; Hicks TL
J Perianesth Nurs; 2019 Dec; 34(6):1088-1105. PubMed ID: 31227296
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of 5HT3-receptor antagonists in postoperative nausea and vomiting: the role of pharmacogenetics.
Theodosopoulou P; Rekatsina M; Staikou C
Minerva Anestesiol; 2023 Jun; 89(6):565-576. PubMed ID: 36852569
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Ramosetron and Palonosetron for Preventing Nausea and Vomiting after Spinal Surgery: Association With ABCB1 Polymorphisms.
Song JW; Shim JK; Choi SH; Soh S; Jang J; Kwak YL
J Neurosurg Anesthesiol; 2017 Oct; 29(4):406-414. PubMed ID: 27564555
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor Taq IA polymorphism is associated with postoperative nausea and vomiting.
Nakagawa M; Kuri M; Kambara N; Tanigami H; Tanaka H; Kishi Y; Hamajima N
J Anesth; 2008; 22(4):397-403. PubMed ID: 19011779
[TBL] [Abstract][Full Text] [Related]
7. Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
Perwitasari DA; Wessels JA; van der Straaten RJ; Baak-Pablo RF; Mustofa M; Hakimi M; Nortier JW; Gelderblom H; Guchelaar HJ
Jpn J Clin Oncol; 2011 Oct; 41(10):1168-76. PubMed ID: 21840870
[TBL] [Abstract][Full Text] [Related]
8. Postoperative nausea and vomiting: The role of the dopamine D2 receptor TaqIA polymorphism.
Frey UH; Schnee C; Achilles M; Silvanus MT; Esser J; Peters J
Eur J Anaesthesiol; 2016 Feb; 33(2):84-9. PubMed ID: 26225495
[TBL] [Abstract][Full Text] [Related]
9. CYP2D6 isoenzyme and ABCB1 gene polymorphisms associated with postoperative nausea and vomiting in women undergoing laparoscopic cholecystectomy: a randomized trial.
Ribeiro AHS; Braga ELC; Ferreira NAG; Olej B; Verçosa N; Antunes LDS; Cavalcanti IL
Braz J Anesthesiol; 2024; 74(3):744423. PubMed ID: 36841429
[TBL] [Abstract][Full Text] [Related]
10. Effect of the allelic variants of ABCB1, CYP2D6 and HTR3B on response of ramosetron to prevent chemotherapy-induced nausea and vomiting in Korean cancer patients.
Kang G; Kim KR; Shim HJ; Hwang JE; Bae WK; Chung IJ; Kim HN; Lee J; Choi K; Shin HY; Kim JK; Jeong SW; Cho SH
Asia Pac J Clin Oncol; 2017 Feb; 13(1):53-60. PubMed ID: 27488933
[TBL] [Abstract][Full Text] [Related]
11. CYP2D6 basic genotyping as a potential tool to improve the antiemetic efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting.
Niewiński PA; Wojciechowski R; Śliwiński M; Hurkacz ME; Głowacka K; Orzechowska-Juzwenko K; Wiela-Hojeńska AK
Adv Clin Exp Med; 2018 Nov; 27(11):1499-1503. PubMed ID: 30058787
[TBL] [Abstract][Full Text] [Related]
12. The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients.
Wesmiller SW; Henker RA; Sereika SM; Donovan HS; Meng L; Gruen GS; Tarkin IS; Conley YP
Biol Res Nurs; 2013 Oct; 15(4):382-9. PubMed ID: 22718526
[TBL] [Abstract][Full Text] [Related]
13. The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?
Candiotti KA; Birnbach DJ; Lubarsky DA; Nhuch F; Kamat A; Koch WH; Nikoloff M; Wu L; Andrews D
Anesthesiology; 2005 Mar; 102(3):543-9. PubMed ID: 15731591
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 2D6 metabolism and 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.
Janicki PK
Med Sci Monit; 2005 Oct; 11(10):RA322-8. PubMed ID: 16192915
[TBL] [Abstract][Full Text] [Related]
15. A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting.
Singh KP; Dhruva AA; Flowers E; Kober KM; Miaskowski C
Crit Rev Oncol Hematol; 2018 Jan; 121():51-61. PubMed ID: 29279099
[TBL] [Abstract][Full Text] [Related]
16. Association of Anti-Emetic Efficacy of Ondansetron with G2677T Polymorphism in a Drug Transporter Gene ABCB1 in Pakistani Population.
Farhat K; Iqbal J; Waheed A; Mansoor Q; Ismail M; Pasha AK
J Coll Physicians Surg Pak; 2015 Jul; 25(7):486-90. PubMed ID: 26208549
[TBL] [Abstract][Full Text] [Related]
17. Association of ABCB1 polymorphisms with the efficacy of ondansetron for postoperative nausea and vomiting.
Choi EM; Lee MG; Lee SH; Choi KW; Choi SH
Anaesthesia; 2010 Oct; 65(10):996-1000. PubMed ID: 20707787
[TBL] [Abstract][Full Text] [Related]
18. Is there a place for genetics in the management of PONV?
Candiotti K; Shrestha C; Silva Ceschim MR
Best Pract Res Clin Anaesthesiol; 2020 Dec; 34(4):713-720. PubMed ID: 33288121
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.
Ho KY; Gan TJ
Curr Opin Anaesthesiol; 2006 Dec; 19(6):606-11. PubMed ID: 17093363
[TBL] [Abstract][Full Text] [Related]
20. A serotonin transporter polymorphism is associated with postoperative nausea and vomiting: An observational study in two different patient cohorts.
Stamer UM; Schmutz M; Wen T; Banz V; Lippuner C; Zhang L; Steffens M; Stüber F
Eur J Anaesthesiol; 2019 Aug; 36(8):566-574. PubMed ID: 31274544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
